Japan's Fujifilm and Taiho Pharma join hands to develop next-generation ADC manufacturing technologies
Singapore, Aug. 5 -- Fujifilm Corporation and Taiho Pharmaceutical have entered into a strategic partnership agreement for the development of manufacturing technologies for next-generation antibody-drug conjugates (ADCs).
Published by HT Digital Content Services with permission from BioSpectrum Asia....
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.